Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and respiratory passages). It is suitable for babies, toddlers and seniors

Common cause of respiratory and lower respiratory infections. Infection can lead to serious complications such as pneumonia and bronchiolitis. Currently, there is no specific treatment for RSV. However, symptoms can be managed with supportive care. Preventive measures include good hygiene, such as frequent hand washing, and avoiding close contact with infected people. RSV diagnostic tests come in a variety of formats, including laboratory-based tests, rapid antigen tests, and molecular tests. Laboratory-based tests, such as ELISA and PCR, provide highly accurate results. Rapid Antigen Diagnostic Tests (RADTs) provide rapid results and are used in point-of-care settings. Molecular detection is highly accurate and widely used in hospitals and diagnostic centers.

The global market for Respiratory Syncytial Virus Diagnostic Tests was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostic Tests, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Respiratory Syncytial Virus Diagnostic Tests by region & country, by Type, and by Application.

The Respiratory Syncytial Virus Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostic Tests.

Market Segmentation

Scope of Respiratory Syncytial Virus Diagnostic Tests - Market Report

Report Metric	Details
Report Name	Respiratory Syncytial Virus Diagnostic Tests - Market
CAGR	5%
Segment by Type:	Detection Box Instrument
Segment by Application	Hospital Specialist Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Respiratory Syncytial Virus Diagnostic Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Respiratory Syncytial Virus Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Respiratory Syncytial Virus Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus Diagnostic Tests - Market report?

Ans: The main players in the Respiratory Syncytial Virus Diagnostic Tests - Market are F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.

What are the Application segmentation covered in the Respiratory Syncytial Virus Diagnostic Tests - Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus Diagnostic Tests - Market report are Hospital, Specialist Clinic, Other

What are the Type segmentation covered in the Respiratory Syncytial Virus Diagnostic Tests - Market report?

Ans: The Types covered in the Respiratory Syncytial Virus Diagnostic Tests - Market report are Detection Box, Instrument

1 Market Overview

1.1 Respiratory Syncytial Virus Diagnostic Tests Product Introduction

1.2 Global Respiratory Syncytial Virus Diagnostic Tests Market Size Forecast

1.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030)

1.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume (2019-2030)

1.2.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Price (2019-2030)

1.3 Respiratory Syncytial Virus Diagnostic Tests Market Trends & Drivers

1.3.1 Respiratory Syncytial Virus Diagnostic Tests Industry Trends

1.3.2 Respiratory Syncytial Virus Diagnostic Tests Market Drivers & Opportunity

1.3.3 Respiratory Syncytial Virus Diagnostic Tests Market Challenges

1.3.4 Respiratory Syncytial Virus Diagnostic Tests Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Respiratory Syncytial Virus Diagnostic Tests Players Revenue Ranking (2023)

2.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Company (2019-2024)

2.3 Global Respiratory Syncytial Virus Diagnostic Tests Players Sales Volume Ranking (2023)

2.4 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Company Players (2019-2024)

2.5 Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Company (2019-2024)

2.6 Key Manufacturers Respiratory Syncytial Virus Diagnostic Tests Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Respiratory Syncytial Virus Diagnostic Tests Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Respiratory Syncytial Virus Diagnostic Tests

2.9 Respiratory Syncytial Virus Diagnostic Tests Market Competitive Analysis

2.9.1 Respiratory Syncytial Virus Diagnostic Tests Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Respiratory Syncytial Virus Diagnostic Tests Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Tests as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Detection Box

3.1.2 Instrument

3.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type

3.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value, by Type (2019-2030)

3.2.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value, by Type (%) (2019-2030)

3.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Type

3.3.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume, by Type (2019-2030)

3.3.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume, by Type (%) (2019-2030)

3.4 Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Specialist Clinic

4.1.3 Other

4.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application

4.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value, by Application (2019-2030)

4.2.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value, by Application (%) (2019-2030)

4.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Application

4.3.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume, by Application (2019-2030)

4.3.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume, by Application (%) (2019-2030)

4.4 Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region

5.1.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (2019-2024)

5.1.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (2025-2030)

5.1.4 Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (%), (2019-2030)

5.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region

5.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (2019-2024)

5.2.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (2025-2030)

5.2.4 Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (%), (2019-2030)

5.3 Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

5.4.2 North America Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

5.5.2 Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

5.6.2 Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

5.7.2 South America Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

5.8.2 Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value

6.2.1 Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.2.2 Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.3.2 United States Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.4.2 Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.5.2 China Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.5.3 China Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.6.2 Japan Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.7.2 South Korea Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.8.2 Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019-2030

6.9.2 India Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

6.9.3 India Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 F. Hoffmann-La Roche AG

7.1.1 F. Hoffmann-La Roche AG Company Information

7.1.2 F. Hoffmann-La Roche AG Introduction and Business Overview

7.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.1.5 F. Hoffmann-La Roche AG Recent Development

7.2 Abbott

7.2.1 Abbott Company Information

7.2.2 Abbott Introduction and Business Overview

7.2.3 Abbott Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Abbott Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.2.5 Abbott Recent Development

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Company Information

7.3.2 Thermo Fisher Scientific Introduction and Business Overview

7.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.3.5 Thermo Fisher Scientific Recent Development

7.4 BD (Becton, Dickinson and Company)

7.4.1 BD (Becton, Dickinson and Company) Company Information

7.4.2 BD (Becton, Dickinson and Company) Introduction and Business Overview

7.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.4.5 BD (Becton, Dickinson and Company) Recent Development

7.5 QuidelOrtho Corporation

7.5.1 QuidelOrtho Corporation Company Information

7.5.2 QuidelOrtho Corporation Introduction and Business Overview

7.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.5.5 QuidelOrtho Corporation Recent Development

7.6 Hologic, Inc.

7.6.1 Hologic, Inc. Company Information

7.6.2 Hologic, Inc. Introduction and Business Overview

7.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.6.5 Hologic, Inc. Recent Development

7.7 Luminex Corporation

7.7.1 Luminex Corporation Company Information

7.7.2 Luminex Corporation Introduction and Business Overview

7.7.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.7.5 Luminex Corporation Recent Development

7.8 Agilent Technologies, Inc.

7.8.1 Agilent Technologies, Inc. Company Information

7.8.2 Agilent Technologies, Inc. Introduction and Business Overview

7.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.8.5 Agilent Technologies, Inc. Recent Development

7.9 Cepheid (Danaher Corporation)

7.9.1 Cepheid (Danaher Corporation) Company Information

7.9.2 Cepheid (Danaher Corporation) Introduction and Business Overview

7.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.9.5 Cepheid (Danaher Corporation) Recent Development

7.10 DiaSorin S.p.A.

7.10.1 DiaSorin S.p.A. Company Information

7.10.2 DiaSorin S.p.A. Introduction and Business Overview

7.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

7.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Product Offerings

7.10.5 DiaSorin S.p.A. Recent Development

8 Industry Chain Analysis

8.1 Respiratory Syncytial Virus Diagnostic Tests Industrial Chain

8.2 Respiratory Syncytial Virus Diagnostic Tests Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Respiratory Syncytial Virus Diagnostic Tests Sales Model

8.5.2 Sales Channel

8.5.3 Respiratory Syncytial Virus Diagnostic Tests Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

Abbott

Thermo Fisher Scientific

BD (Becton, Dickinson and Company)

QuidelOrtho Corporation

Hologic Inc

Luminex Corporation

Agilent Technologies Inc

Cepheid(Danaher Corporation)

DiaSorin

List of Tables

Table 1. Respiratory Syncytial Virus Diagnostic Tests Market Trends

Table 2. Respiratory Syncytial Virus Diagnostic Tests Market Drivers & Opportunity

Table 3. Respiratory Syncytial Virus Diagnostic Tests Market Challenges

Table 4. Respiratory Syncytial Virus Diagnostic Tests Market Restraints

Table 5. Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Company (2019-2024)

Table 7. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Respiratory Syncytial Virus Diagnostic Tests Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Respiratory Syncytial Virus Diagnostic Tests Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Respiratory Syncytial Virus Diagnostic Tests Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Respiratory Syncytial Virus Diagnostic Tests

Table 13. Global Respiratory Syncytial Virus Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Tests as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Respiratory Syncytial Virus Diagnostic Tests Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Respiratory Syncytial Virus Diagnostic Tests Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Respiratory Syncytial Virus Diagnostic Tests Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Respiratory Syncytial Virus Diagnostic Tests Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (2019-2024) & (%)

Table 44. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Region (2025-2030) & (%)

Table 45. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (2019-2024) & (%)

Table 49. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Region (2025-2030) & (%)

Table 50. Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Volume, (2025-2030) & (K Units)

Table 57. F. Hoffmann-La Roche AG Company Information

Table 58. F. Hoffmann-La Roche AG Introduction and Business Overview

Table 59. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 61. F. Hoffmann-La Roche AG Recent Development

Table 62. Abbott Company Information

Table 63. Abbott Introduction and Business Overview

Table 64. Abbott Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Abbott Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 66. Abbott Recent Development

Table 67. Thermo Fisher Scientific Company Information

Table 68. Thermo Fisher Scientific Introduction and Business Overview

Table 69. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 71. Thermo Fisher Scientific Recent Development

Table 72. BD (Becton, Dickinson and Company) Company Information

Table 73. BD (Becton, Dickinson and Company) Introduction and Business Overview

Table 74. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 76. BD (Becton, Dickinson and Company) Recent Development

Table 77. QuidelOrtho Corporation Company Information

Table 78. QuidelOrtho Corporation Introduction and Business Overview

Table 79. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 81. QuidelOrtho Corporation Recent Development

Table 82. Hologic, Inc. Company Information

Table 83. Hologic, Inc. Introduction and Business Overview

Table 84. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 86. Hologic, Inc. Recent Development

Table 87. Luminex Corporation Company Information

Table 88. Luminex Corporation Introduction and Business Overview

Table 89. Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 91. Luminex Corporation Recent Development

Table 92. Agilent Technologies, Inc. Company Information

Table 93. Agilent Technologies, Inc. Introduction and Business Overview

Table 94. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 96. Agilent Technologies, Inc. Recent Development

Table 97. Cepheid (Danaher Corporation) Company Information

Table 98. Cepheid (Danaher Corporation) Introduction and Business Overview

Table 99. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 101. Cepheid (Danaher Corporation) Recent Development

Table 102. DiaSorin S.p.A. Company Information

Table 103. DiaSorin S.p.A. Introduction and Business Overview

Table 104. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Product Offerings

Table 106. DiaSorin S.p.A. Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Respiratory Syncytial Virus Diagnostic Tests Downstream Customers

Table 110. Respiratory Syncytial Virus Diagnostic Tests Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Respiratory Syncytial Virus Diagnostic Tests Product Picture

Figure 2. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume (2019-2030) & (K Units)

Figure 5. Global Respiratory Syncytial Virus Diagnostic Tests Sales Price (2019-2030) & (US$/Unit)

Figure 6. Respiratory Syncytial Virus Diagnostic Tests Report Years Considered

Figure 7. Global Respiratory Syncytial Virus Diagnostic Tests Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Respiratory Syncytial Virus Diagnostic Tests Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Syncytial Virus Diagnostic Tests Revenue in 2023

Figure 10. Respiratory Syncytial Virus Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Detection Box Picture

Figure 12. Instrument Picture

Figure 13. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Respiratory Syncytial Virus Diagnostic Tests Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Specialist Clinic

Figure 20. Product Picture of Other

Figure 21. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Respiratory Syncytial Virus Diagnostic Tests Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Respiratory Syncytial Virus Diagnostic Tests Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Respiratory Syncytial Virus Diagnostic Tests Price by Application (2019-2030) & (US$/Unit)

Figure 26. North America Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Respiratory Syncytial Virus Diagnostic Tests Sales Volume (%), (2019-2030)

Figure 38. United States Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 44. China Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 46. China Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 56. India Respiratory Syncytial Virus Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Respiratory Syncytial Virus Diagnostic Tests Sales Value by Type (%), 2023 VS 2030

Figure 58. India Respiratory Syncytial Virus Diagnostic Tests Sales Value by Application (%), 2023 VS 2030

Figure 59. Respiratory Syncytial Virus Diagnostic Tests Industrial Chain

Figure 60. Respiratory Syncytial Virus Diagnostic Tests Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions